Position in CDNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$195,937
-$174,265 QoQ
Shares Held
6,875
-67.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#168
of 225 holders
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aquatic Capital Management LLC holds $53,773,112 across 15 Diagnostics & Research names. CDNA ranks #13 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
26,113 | $13,092,013 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
8,714 | $11,132,222 | |
| 3 | DHR |
Danaher Corp /De/
|
35,025 | $6,671,562 | |
| 4 | A |
Agilent Technologies, Inc.
|
34,942 | $4,641,345 | |
| 5 | WAT |
Waters Corp /De/
|
10,897 | $4,086,810 | |
| 6 | TWST |
Twist Bioscience Corp
|
35,574 | $3,659,853 | |
| 7 | NTRA |
Natera, Inc.
|
11,644 | $3,160,763 | |
| 8 | RVTY |
Revvity, Inc.
|
23,460 | $2,610,159 |
All Filings in CDNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $195,937 | 6,875 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $370,202 | 21,325 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $981,111 | 52,076 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,304,848 | 89,742 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $39,158 | 2,004 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $515,617 | 24,083 | Shares | Sole | 2025-02-14 | |
| 2022-09-30 | $158,286 | 9,300 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $107,400 | 5,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,699 | 100 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||